Company Profiles

driven by the PitchBook Platform

KeyBay Pharma

2002 FOUNDED
PRIVATE STATUS
Later Stage VC LATEST DEAL TYPE
$50K LATEST DEAL AMOUNT
2 INVESTORS
Description

Provider of anti-infective therapeutics and orphan drugs. The company researches and develops drugs for the treatment of serious lung infections which commonly affect children with cystic fibrosis.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Primary Office
5001 Baum Boulevard
Suite 490
Pittsburgh, PA 15213
United States

+1 (412) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore KeyBay Pharma’s full profile, request a free trial.

KeyBay Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 28-Aug-2008 $50K 00000 Completed Generating Revenue
2. Early Stage VC 14-Jul-2005 00000 00000 Completed Startup
1. Early Stage VC 09-Sep-2004 $99K $99K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

KeyBay Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Innovation Works Venture Capital Minority 000 0000 000000 0
Pittsburgh Life Sciences Greenhouse Venture Capital Minority 000 0000 000000 0

KeyBay Pharma Executive Team (1)

Name Title Board
Seat
Contact
Info
Robert Fatora Ph.D Owner, Chief Executive Officer & President
Questions or concerns about this profile? Reach out to website-support@pitchbook.com